Phase 1 trial evaluation of SYS6006's COVID-19 mRNA vaccine's immunogenicity and safety.

Published Date: 05 Jul 2023

More than 600 million confirmed cases and 6.5 million fatalities have been attributed to the COVID-19 pandemic, which was brought on by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). mRNA-based vaccines have become popular.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

New protein target discovered for childhood medulloblastomas

3.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

4.

Papillary thyroid cancer: New markers offer hope for tailored treatment

5.

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot